Skip to content
LineaRx Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
September 30, 2022
Read More email
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18, 2022
Read More email
APDN and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17, 2020
Read More email
APDN Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9, 2020
Read More email
APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program
June 8, 2020
Read More email
APDN and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
May 4, 2020
Read More email
Italian Biotech Startup Racing To Develop A Coronavirus Vaccine
April 21, 2020
Read More email
LI Biotech Speeds COVID-19 Vaccine Candidates To Italy
April 15, 2020
Read More email
APDN Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
April 15, 2020
Read More email
APDN COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models
March 18, 2020
Read More email
Stony Brook firm working on coronavirus vaccine
March 3, 2020
Read More email
Applied DNA, Takis Biotech design four Covid-19 vaccine candidates
March 3, 2020
Read More email
Applied DNA Speeds Coronavirus Vaccines Toward Tests
March 2, 2020
Read More email
APDN Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2, 2020
Read More email
Applied DNA To Speed Up Coronavirus Countermeasures
February 13, 2020
Read More email
Applied DNA, Takis Biotech partner on coronavirus vaccine
February 11, 2020
Read More email
LineaRx and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
February 7, 2020
Read More email
Linear DNA Combo Shows Punch In Cancer Fight
September 20, 2019
Read More email
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
September 19, 2019
Read More email
LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1, 2019
Read More email
LineaRx to Collaborate with Italian Companies Takis and Evvivax on Cancer Vaccines
September 20, 2018
Read More email
LineaRx Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20, 2018
Read More email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
